Home/Filings/4/0001209191-18-017783
4//SEC Filing

Kowalski Mark 4

Accession 0001209191-18-017783

CIK 0001290149other

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 5:56 PM ET

Size

5.6 KB

Accession

0001209191-18-017783

Insider Transaction Report

Form 4
Period: 2018-03-06
Kowalski Mark
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2018-03-06+155,000155,000 total
    Exercise: $2.36Exp: 2028-03-06Common Stock (155,000 underlying)
Footnotes (1)
  • [F1]The option vests as to 25% of the total shares on January 1, 2019, and then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested on January 1, 2022, subject to the reporting person's provision of service to the issuer on each vesting date.

Issuer

Sierra Oncology, Inc.

CIK 0001290149

Entity typeother

Related Parties

1
  • filerCIK 0001628357

Filing Metadata

Form type
4
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 5:56 PM ET
Size
5.6 KB